Dentsply International Stock News

Reinhart Partners Inc. trimmed its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.5% in the third quarter, HoldingsChannel.com reports. The fund owned 198,318 shares of the medical instruments suppliers stock after selling 16,050 shares during the quarter. Reinhart Partners Inc.s holdings in DENTSPLY SIRONA were worth $11,512,000 at the end of the most recent reporting []

Stratos Wealth Advisors LLC purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,970 shares of the medical instruments suppliers stock, valued at approximately $463,000. Other hedge funds and other institutional investors also []

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) CEO Donald M. Jr. Casey bought 20,000 shares of the stock in a transaction dated Wednesday, December 1st. The shares were acquired at an average price of $49.78 per share, for a total transaction of $995,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which []

Ellevest Inc. trimmed its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 25.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,293 shares of the medical instruments suppliers stock after selling 452 shares during the quarter. Ellevest Inc.s holdings in DENTSPLY SIRONA []

Related Stocks: XRAY ,

Meet Suresmile aligners by Dentsply Sirona the innovative clear aligner system. With predictable outcomes, clinically superior planning capabilities and patient satisfaction, combined with the reassurance of a 20-year heritage in digital orthodontic treatment planning, Suresmile clear aligners delivers a solution you can trust! Suresmile has already become a leading name in the provision of Continued

Market Overview: The most durable and easy to clean specialty medical chairs use are designed for durability and ergonomics. These chairs are designed to minimize stress and improve the working environment. They can be found in a variety of styles, including

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woe persists.

Equities research analysts expect DENTSPLY SIRONA Inc. (NASDAQ:XRAY) to announce sales of $1.13 billion for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for DENTSPLY SIRONAs earnings, with the highest sales estimate coming in at $1.16 billion and the lowest estimate coming in at $1.10 billion. DENTSPLY SIRONA posted sales of []

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) SVP Lisa Yankie sold 1,903 shares of the stock in a transaction dated Friday, November 19th. The stock was sold at an average price of $52.63, for a total value of $100,154.89. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. NASDAQ:XRAY […]

The market for dental laboratories is anticipated to experience a tremendous growth in coming years due to rise in prevalence of periodontal diseases. One of the key players, DENTSPLY SIRONA Inc. is at present trading with a market value of

Berman Capital Advisors LLC reduced its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 21.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 915 shares of the medical instruments suppliers stock after selling 253 shares during the quarter. Berman Capital Advisors LLCs holdings in DENTSPLY SIRONA []

Comerica Bank reduced its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 4.0% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 60,464 shares of the medical instruments suppliers stock after selling 2,542 shares during the period. Comerica Banks holdings in DENTSPLY SIRONA were worth $3,621,000 as of its []

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) insider Walter Petersohn sold 86,431 shares of the companys stock in a transaction that occurred on Wednesday, November 17th. The shares were sold at an average price of $54.18, for a total value of $4,682,831.58. The transaction was disclosed in a legal filing with the SEC, which can be accessed through []